Evidence map›Paper›PMID 28061821›Full record

ArticleBMC infectious diseases2017

Unusual manifestation of Helicobacter cinaedi infection: a case report of intracranial subdural empyema and bacteremia.

Toshimasa Hayashi, Junko Tomida, Yoshiaki Kawamura, Masakazu Yoshida, Ikuyo Yokozawa, Shingaku Kaneko

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Draft Genome Sequence ofMicrobiology resource announcements · 2022
    Article
  2. Surgical neurology international · 2021
    Article
  3. Article
  4. A Case Of RecurrentJournal of bone and joint infection · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Toshimasa HayashiDivision of Infectious Diseases, Maebashi Red Cross Hospital, Asahicho 3-21-36, Maebashi, Gunma, 371-0014, Japan. t-hayashi@maebashi.jrc.or.jp.ORCID 0000-0001-8803-0914
Junko TomidaDepartment of Microbiology, School of Pharmacy, Aichi Gakuin University, Nisshin, Japan.
Yoshiaki KawamuraDepartment of Microbiology, School of Pharmacy, Aichi Gakuin University, Nisshin, Japan.
Masakazu YoshidaDivision of Clinical Laboratory, Maebashi Red Cross Hospital, Maebashi, Japan.
Ikuyo YokozawaDivision of Clinical Laboratory, Maebashi Red Cross Hospital, Maebashi, Japan.
Shingaku KanekoDivision of Clinical Laboratory, Maebashi Red Cross Hospital, Maebashi, Japan.
Maebashi Red Cross Hospital · JPAichi Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere have been various reports concerning Helicobacter cinaedi infections. However, few reports have examined central nervous system infections. CASE PRESENTATION: A 52-year-old man was transferred from the local hospital because of a persistent headache and suspected intracranial subdural empyema. Neurosurgical drainage was performed via burr holes. Gram staining and results from abscess cultures were negative. The blood culture yielded H. cinaedi. He was given an antibiotic regimen consisting of 2 g of ceftriaxone twice a day, but the size of the abscess was not reduced in size at all after 3 weeks of treatment. Neurosurgical drainage was performed again, and the antimicrobial regimen was switched to 2 g of meropenem 3 times a day. The size of the abscess was reduced after 2 weeks of the second drainage and antimicrobial drug change to meropenem. After 4 weeks treatment with meropenem, the patient was discharged, and his symptoms had completely resolved.

conclusionsH. cinaedi infection should be considered in the differential diagnosis of subdural empyema cases for which Gram staining and abscess culture results are negative. Meropenem can be a first-line drug of choice or an effective alternative treatment for H. cinaedi central nervous system infections.

Indexed as

AbscessAnti-Bacterial AgentsAnti-Infective AgentsBacteremiaCeftriaxoneDrainageEmpyema, SubduralHelicobacterHelicobacter InfectionsHumansMaleMeropenemMiddle AgedThienamycinsTreatment OutcomeAnti-Bacterial AgentsAnti-Infective AgentsCeftriaxoneMeropenemThienamycinsAntimicrobial susceptibility testingCase reportHelicobacter cinaediIntracranial subdural empyema

Identifiers

PMID28061821
PMCPMC5219691
OpenAlexW2568072858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.